Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in the two business units Human Pharma and Animal Health.
Boehringer Ingelheim Bulgaria Rep Office is a subsidiary of Boehringer Ingelheim RCV and has been present on the Bulgarian market since 1993. Our marketing activities in Bulgaria are focused on providing breakthrough and innovative therapies primarily on the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology.
Learn more at www.boehringer-ingelheim.com
